$PRCT
PROCEPT BioRobotics Corp Stock $prct

$prct Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000162828021022015 Filed on November 05, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$10.14M	$8.668M	$2.107M
YoY Change	31.37%	311.39%
Cost Of Revenue	$5.622M	$4.428M	$2.138M
YoY Change	-37.34%	107.11%
Gross Profit	$4.516M	$4.240M	-$31.00K
YoY Change	-459.84%	-13777.42%
Gross Profit Margin	44.55%	48.92%	-1.47%
Selling, General & Admin	$16.27M	$12.12M	$7.054M
YoY Change	-46.25%	71.79%
% of Gross Profit	360.3%	285.8%
Research & Development	$5.076M	$4.919M	$3.893M
YoY Change	-68.81%	26.35%
% of Gross Profit	112.4%	116.01%
Depreciation & Amortization	$763.0K	$796.0K	$715.0K
YoY Change	6.71%	11.33%
% of Gross Profit	16.9%	18.77%
Operating Expenses	$21.35M	$17.04M	$10.95M
YoY Change	-54.14%	55.63%
Operating Profit	-$16.83M	-$12.80M	-$10.98M
YoY Change	-64.79%	16.57%
Interest Expense	-$1.503M	$1.469M	$1.387M
YoY Change	-72.18%	5.91%
% of Operating Profit
Other Income/Expense, Net	-$14.00K	-$52.00K	$18.00K
YoY Change	-107.57%	-388.89%
Pretax Income	-$18.35M	-$14.10M	-$12.01M
YoY Change	-65.39%	17.45%
Income Tax
% Of Pretax Income
Net Earnings	-$18.35M	-$14.10M	-$12.01M
YoY Change	-65.39%	17.45%
Net Earnings / Revenue	-180.98%	-162.7%	-569.91%
Basic Earnings Per Share		-$1.22	-$2.77
Diluted Earnings Per Share	-$414.3K	-$1.22	-$2.77
COMMON SHARES
Basic Shares Outstanding	43.50M shares	11.58M shares	4.329M shares
Diluted Shares Outstanding		11.58M shares	4.329M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$304.3M	$320.5M
YoY Change
Cash & Equivalents	$304.3M	$320.5M	$113.3M
Short-Term Investments
Other Short-Term Assets	$3.412M	$1.922M
YoY Change
Inventory	$13.15M	$10.40M
Prepaid Expenses
Receivables	$4.464M	$6.353M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$326.2M	$339.5M
YoY Change	195.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.045M	$5.731M
YoY Change	-39.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$777.0K
YoY Change
Total Long-Term Assets	$10.85M	$11.99M
YoY Change	-30.95%
TOTAL ASSETS
Total Short-Term Assets	$326.2M	$339.5M
Total Long-Term Assets	$10.85M	$11.99M
Total Assets	$337.0M	$351.5M
YoY Change	167.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.029M	$3.590M
YoY Change	63.63%
Accrued Expenses	$11.21M	$8.492M
YoY Change
Deferred Revenue	$1.025M	$848.0K
YoY Change	339.91%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change	-100.0%
Total Short-Term Liabilities	$16.24M	$14.18M
YoY Change	11.81%
LONG-TERM LIABILITIES
Long-Term Debt	$50.00M	$49.76M
YoY Change	12.6%
Other Long-Term Liabilities	$200.0K	$200.0K
YoY Change	0.0%
Total Long-Term Liabilities	$50.20M	$49.96M
YoY Change	12.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.24M	$14.18M
Total Long-Term Liabilities	$50.20M	$49.96M
Total Liabilities	$69.93M	$68.15M
YoY Change	7.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$261.5M	-$243.2M
YoY Change	29.68%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$267.1M	$283.3M	-$168.4M
YoY Change
Total Liabilities & Shareholders Equity	$337.0M	$351.5M
YoY Change	167.54%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$18.35M	-$14.10M	-$12.01M
YoY Change	-65.39%	17.45%
Depreciation, Depletion And Amortization	$763.0K	$796.0K	$715.0K
YoY Change	6.71%	11.33%
Cash From Operating Activities	-$16.48M	-$12.75M	-$10.95M
YoY Change	22.54%	16.47%
INVESTING ACTIVITIES
Capital Expenditures	-$332.0K	-$111.0K	-$20.00K
YoY Change	3588.89%	455.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$332.0K	-$111.0K	-$20.00K
YoY Change	3588.89%	455.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	644.0K	174.1M	79.24M
YoY Change	171.73%	119.75%
NET CHANGE
Cash From Operating Activities	-16.48M	-12.75M	-10.95M
Cash From Investing Activities	-332.0K	-111.0K	-20.00K
Cash From Financing Activities	644.0K	174.1M	79.24M
Net Change In Cash	-16.16M	161.3M	68.27M
YoY Change	22.3%	136.21%
FREE CASH FLOW
Cash From Operating Activities	-$16.48M	-$12.75M	-$10.95M
Capital Expenditures	-$332.0K	-$111.0K	-$20.00K
Free Cash Flow	-$16.14M	-$12.64M	-$10.93M
YoY Change	20.15%	15.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001588978
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.2105263158
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40797
	dei	Entity Registrant Name EntityRegistrantName	PROCEPT BioRobotics Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0199180
	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Island Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Redwood City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94065
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	320484000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100130000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6353000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1549000	USD
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	232-7200
	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value per share
	dei	Trading Symbol TradingSymbol	PRCT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43496831	shares
CY2021Q3	us-gaap	Inventory Net InventoryNet	10401000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	6924000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2232000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1653000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	339470000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	110256000	USD
CY2021Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	777000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	777000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5731000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8274000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3667000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4641000	USD
CY2021Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1818000	USD
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	2023000	USD
CY2021Q3	us-gaap	Assets Assets	351463000	USD
CY2020Q4	us-gaap	Assets Assets	125971000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4640000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3590000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1240000	USD
CY2021Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4875000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4551000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2032000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1708000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	848000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	233000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	177000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2834000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1977000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14179000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14526000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	68151000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	49762000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	44407000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2550000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4096000	USD
CY2021Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1460000	USD
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1782000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	65011000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	26984000	shares
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	25402000	shares
CY2021Q3	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	245768000	USD
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43472000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43472000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4713000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4713000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	526526000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-182894000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18788000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-41000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-243173000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-201668000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	283312000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	351463000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	125971000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8668000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2107000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24335000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4496000	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	4428000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	2138000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	12986000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	6221000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	4240000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	-31000	USD
	us-gaap	Gross Profit GrossProfit	11349000	USD
	us-gaap	Gross Profit GrossProfit	-1725000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4919000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3893000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13917000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11732000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12118000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7054000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34765000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21138000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	17037000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	10947000	USD
	us-gaap	Operating Expenses OperatingExpenses	48682000	USD
	us-gaap	Interest Expense InterestExpense	4370000	USD
	us-gaap	Operating Expenses OperatingExpenses	32870000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12797000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10978000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37333000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-34595000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	1469000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	1387000	USD
	us-gaap	Interest Expense InterestExpense	3490000	USD
CY2021Q3	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	163000	USD
CY2020Q3	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	357000	USD
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	198000	USD
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	344000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14103000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-12008000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41505000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-37741000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.77
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.77
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.64
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.34
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11580000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11580000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4329000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4329000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7361000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7361000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3327000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3327000	shares
CY2021Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-2000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-16000	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-27000	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	3000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14105000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12024000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41532000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37738000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-182894000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1225000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	650000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-16000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-12822000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	725000	USD
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-193857000	USD
CY2021Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	290000	USD
CY2021Q2	prct	Temporary Equity Stock Issued During Period Shares Warrant Exercises TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises	4448000	shares
CY2021Q2	prct	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	84710000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1415000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-9000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14580000	USD
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	29850000	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	328564000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-206306000	USD
CY2021Q3	prct	Temporary Equity Stock Issued During Period Shares Warrant Exercises TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises	62000	shares
CY2021Q3	prct	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	970000	USD
CY2021Q3	prct	Temporary Equity Shares Conversion Of Convertible Securities TemporaryEquitySharesConversionOfConvertibleSecurities	29912000	shares
CY2021Q3	prct	Temporary Equity Amount Conversion Of Convertible Securities TemporaryEquityAmountConversionOfConvertibleSecurities	329534000	USD
CY2020Q1	prct	Temporary Equity Stock Issued During Period Shares Warrant Exercises TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises	75000	shares
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	561000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	329534000	USD
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	16076000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	172409000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	855000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	925000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14103000	USD
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	283312000	USD
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	20998000	shares
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	173068000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-143837000	USD
CY2020Q1	prct	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	379000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1024000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	445000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-166541000	USD
CY2020Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	21118000	shares
CY2020Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	173677000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13126000	USD
CY2020Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	21073000	shares
CY2020Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	173447000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-155385000	USD
CY2020Q2	prct	Temporary Equity Stock Issued During Period Shares Warrant Exercises TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises	45000	shares
CY2020Q2	prct	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	230000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	979000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	26000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-12606000	USD
CY2020Q3	prct	Temporary Equity Shares Conversion Of Convertible Securities TemporaryEquitySharesConversionOfConvertibleSecurities	1474000	shares
CY2020Q3	prct	Temporary Equity Amount Conversion Of Convertible Securities TemporaryEquityAmountConversionOfConvertibleSecurities	9520000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9520000	USD
CY2020Q3	prct	Temporary Equity Stock Issued During Period Shares Warrant Exercises TemporaryEquityStockIssuedDuringPeriodSharesWarrantExercises	531000	shares
CY2020Q3	prct	Temporary Equity Stock Issued During Period Value Warrant Exercises TemporaryEquityStockIssuedDuringPeriodValueWarrantExercises	3209000	USD
CY2020Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	496000	USD
CY2020Q3	prct	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	5227000	shares
CY2020Q3	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	76486000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	51000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	563000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-16000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-12008000	USD
CY2020Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402000	shares
CY2020Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243852000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-168431000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41505000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-37741000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2561000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2145000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1569000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	537000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	22000	USD
	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	-235000	USD
	prct	Fair Value Adjustment Of Warrants And Gain Loss On Derivative Instruments Net Pretax FairValueAdjustmentOfWarrantsAndGainLossOnDerivativeInstrumentsNetPretax	-408000	USD
	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	249000	USD
	prct	Non Cash Lease Accretion Expense NonCashLeaseAccretionExpense	82000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4804000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	729000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3580000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	895000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	606000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	200000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2362000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-262000	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	235000	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	1307000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	804000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	224000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-260000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	866000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	615000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	182000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	707000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-672000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40858000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34898000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	260000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-224000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3495000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2051000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	24685000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	858000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3310000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	172409000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	261472000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	106534000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	220354000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	71412000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	100907000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42712000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321261000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114124000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	320484000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	113347000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	777000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	777000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321261000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114124000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3566000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2785000	USD
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	-1227000	USD
	prct	Transfer From Inventory To Property And Equipment Net TransferFromInventoryToPropertyAndEquipmentNet	1470000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	200000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	200000	USD
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	819000	USD
	prct	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	320500000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100100000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-243200000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-201700000	USD
	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in the consolidated financial statements. Management uses significant judgment when making estimates related to its common stock valuation in periods before the Company’s IPO and related stock-based compensation, right-of-use lease asset, lease liability, the valuations of the redeemable convertible preferred stock warrant liability and loan facility derivative liability, as well as certain accrued liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2021Q3	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	13200000	USD
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2900000	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash, cash equivalents and, to a lesser extent, accounts receivable. The Company believes that credit risk in its accounts receivable is mitigated by its credit evaluation process, relatively short collection terms and diversity of its customer base. The Company generally does not require collateral and losses on accounts receivable have historically been within management’s expectations. </span></div>The Company’s investment policy limits investments to certain types of debt securities issued by the U.S. government, its agencies, and institutions with investment-grade credit ratings, as well as corporate debt or commercial paper issued by the highest quality financial and non-financial companies, and places restrictions on maturities and concentration by type and issuer. The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash and cash equivalents and issuers of investments to the extent recorded on the balance sheets. The Company has limited its credit risk associated with cash and cash equivalents by placing its investments with banks it believes are highly creditworthy and with highly rated investments.
	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets consist primarily of property and equipment and intangible assets, net, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require that a long-lived asset be tested for possible impairment, the Company compares the undiscounted cash flows expected to be generated by the asset group to the carrying amount of the </span></div>asset group. If the carrying amount of the long-lived asset is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying amount exceeds its fair value. The Company determines fair value using the income approach based on the present value of expected future cash flows or other appropriate measures of estimated fair value. The Company’s cash flow assumptions consider historical and forecasted revenue and operating costs and other relevant factors. Since inception, the Company has not recorded impairment charges on its long-lived assets.
CY2020Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2021Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
	prct	Temporary Equity Dividends TemporaryEquityDividends	0.08
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
	prct	Product Warranty Term ProductWarrantyTerm	P1Y
	prct	Service Agreement Amortization Period ServiceAgreementAmortizationPeriod	P1Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2400000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1500000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8668000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2107000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24335000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4496000	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2500000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-14103000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-12008000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-41505000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-37741000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11580000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11580000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4329000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4329000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7361000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7361000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3327000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3327000	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.34
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.77
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.64
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6607000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31629000	shares
CY2021Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	579000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	339000	USD
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	4602000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2647000	USD
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	612000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	51000	USD
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5187000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4226000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	10401000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	6924000	USD
CY2021Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	482000	USD
CY2021Q3	prct	Prepaid Inventory PrepaidInventory	310000	USD
CY2020Q4	prct	Prepaid Inventory PrepaidInventory	553000	USD
CY2021Q3	prct	Prepaid Software PrepaidSoftware	580000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2020Q4	prct	Prepaid Software PrepaidSoftware	375000	USD
CY2021Q3	us-gaap	Prepaid Rent PrepaidRent	252000	USD
CY2020Q4	us-gaap	Prepaid Rent PrepaidRent	245000	USD
CY2021Q3	us-gaap	Prepaid Insurance PrepaidInsurance	447000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	124000	USD
CY2021Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	643000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	356000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2232000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1653000	USD
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	302000	USD
	prct	Temporary Equity Dividends TemporaryEquityDividends	0.08
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12165000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13062000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6434000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4788000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5731000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8274000	USD
CY2021Q3	prct	Accrued Purchases AccruedPurchases	134000	USD
CY2020Q4	prct	Accrued Purchases AccruedPurchases	432000	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	390000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	403000	USD
CY2021Q3	prct	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	117000	USD
CY2020Q4	prct	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	47000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1132000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	454000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2834000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1977000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	22000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	23000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	49000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	161000	USD
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-16000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-78000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-233000	USD
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	177000	USD
CY2020Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	174000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	158000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-41000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-52000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	18000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-87000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	USD
CY2021Q3	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	163000	USD
CY2020Q3	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	357000	USD
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	198000	USD
	prct	Interest And Other Income Expense InterestAndOtherIncomeExpense	344000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	700000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	500000	USD
CY2020Q4	prct	Finite Lived Intangible Asset Expected Annual Amortization Expense FiniteLivedIntangibleAssetExpectedAnnualAmortizationExpense	300000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	26983984	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	25402402	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	25402402	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243854000	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2021Q3	prct	Temporary Equity Voting Rights Number Of Votes Per Share Of Common Stock If Converted TemporaryEquityVotingRightsNumberOfVotesPerShareOfCommonStockIfConverted	1	customer
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	29912264	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	98700000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	6900000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	218500000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	9900000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5100000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1800000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1200000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	USD
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	500000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1500000	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	55100000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	56700000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	925000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	563000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2300000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1569000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	9700000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6500000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	604000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	604000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2445000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	2445000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2092000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	12500000	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	14592000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	37500000	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Maturity Year Three OperatingLeaseLiabilityAndLongTermDebtMaturityYearThree	37500000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5141000	USD
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	55141000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	559000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	238000	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	797000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4582000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	49762000	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	54344000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2032000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	2032000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2550000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	49762000	USD
CY2021Q3	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	52312000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2179000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Maturity Remainder Of Fiscal Year OperatingLeaseLiabilityAndLongTermDebtMaturityRemainderOfFiscalYear	2179000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2445000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6250000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Maturity Year One OperatingLeaseLiabilityAndLongTermDebtMaturityYearOne	8695000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2092000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	25000000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Maturity Year Two OperatingLeaseLiabilityAndLongTermDebtMaturityYearTwo	27092000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	18750000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Maturity Year Three OperatingLeaseLiabilityAndLongTermDebtMaturityYearThree	18750000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6716000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	50000000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Maturity Gross OperatingLeaseLiabilityAndLongTermDebtMaturityGross	56716000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	912000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1042000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Maturity Unamortized Debt Discount OperatingLeaseLiabilityAndLongTermDebtMaturityUnamortizedDebtDiscount	1954000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5804000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	48958000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt OperatingLeaseLiabilityAndLongTermDebt	54762000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1708000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4551000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Current OperatingLeaseLiabilityAndLongTermDebtCurrent	6259000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4096000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	44407000	USD
CY2020Q4	prct	Operating Lease Liability And Long Term Debt Excluding Current Maturities OperatingLeaseLiabilityAndLongTermDebtExcludingCurrentMaturities	48503000	USD

Files In Submission

Name	View Source	Status
0001628280-21-022015-index-headers.html	Edgar Link	pending
0001628280-21-022015-index.html	Edgar Link	pending
0001628280-21-022015.txt	Edgar Link	pending
0001628280-21-022015-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prct-20210930.htm	Edgar Link	pending
prct-20210930.xsd	Edgar Link	pending
prct-20210930_cal.xml	Edgar Link	unprocessable
prct-20210930_def.xml	Edgar Link	unprocessable
prct-20210930_htm.xml	Edgar Link	completed
prct-20210930_lab.xml	Edgar Link	unprocessable
prct-20210930_pre.xml	Edgar Link	unprocessable
prct-ex311soxcertification.htm	Edgar Link	pending
prct-ex312soxcertification.htm	Edgar Link	pending
prct-ex321soxcertification.htm	Edgar Link	pending
prct-ex322soxcertification.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRCT
PROCEPT BioRobotics Corp Stock $prct

2021 Q4 Form 10-Q Financial Statement

#000162828021022015 Filed on November 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT PROCEPT BioRobotics Corp Stock $prct

2021 Q4 Form 10-Q Financial Statement

#000162828021022015 Filed on November 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRCT
PROCEPT BioRobotics Corp Stock $prct